ABCB1, also known as P-glycoprotein, is one of the best characterized ABC transporters involved in restricting the efficacy of treatment in CRC and its elevated levels could predict worse prognosis [63, 64]. This evidence concerns the gene ABCG2 and colorectal carcinoma.